Glucametacin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Glucametacin''' is a | {{Short description|A non-steroidal anti-inflammatory drug}} | ||
{{Drugbox | |||
| image = Glucametacin.svg | |||
| image2 = | |||
| caption = Chemical structure of Glucametacin | |||
}} | |||
'''Glucametacin''' is a non-steroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. It is a derivative of indomethacin, a well-known NSAID, and is used in the treatment of various inflammatory conditions. | |||
==Pharmacology== | ==Pharmacology== | ||
Glucametacin | Glucametacin works by inhibiting the [[cyclooxygenase]] (COX) enzymes, which are involved in the synthesis of [[prostaglandins]]. Prostaglandins are mediators of inflammation and pain, and by reducing their production, glucametacin helps alleviate symptoms associated with inflammatory conditions. | ||
==Medical uses== | |||
Glucametacin is used in the management of conditions such as: | |||
* [[Rheumatoid arthritis]] | |||
* [[Osteoarthritis]] | |||
* [[Ankylosing spondylitis]] | |||
* Acute musculoskeletal disorders | |||
== | ==Side effects== | ||
As with other NSAIDs, glucametacin can cause a range of side effects, including: | |||
* [[Gastrointestinal bleeding]] | |||
* [[Ulcer]] formation | |||
* [[Renal impairment]] | |||
* [[Cardiovascular events]] | |||
== | ==Mechanism of action== | ||
[[File:Glucametacin.svg|thumb|right|Chemical structure of Glucametacin]] | |||
Glucametacin inhibits both COX-1 and COX-2 enzymes, though it has a higher affinity for COX-2. This selective inhibition reduces the production of pro-inflammatory prostaglandins while sparing those that protect the gastric mucosa and maintain renal blood flow. | |||
== | ==Chemical properties== | ||
Glucametacin is chemically related to indomethacin, with modifications that enhance its pharmacokinetic profile. It is a lipophilic compound, which allows it to penetrate tissues effectively, contributing to its anti-inflammatory effects. | |||
== | ==History== | ||
Glucametacin was developed as part of efforts to create NSAIDs with improved safety profiles compared to earlier drugs like indomethacin. Its development focused on reducing gastrointestinal side effects while maintaining efficacy. | |||
==Related pages== | |||
* [[Non-steroidal anti-inflammatory drug]] | * [[Non-steroidal anti-inflammatory drug]] | ||
* [[Indomethacin]] | * [[Indomethacin]] | ||
* [[Cyclooxygenase]] | * [[Cyclooxygenase]] | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
Latest revision as of 03:48, 13 February 2025
A non-steroidal anti-inflammatory drug
| Glucametacin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Glucametacin is a non-steroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. It is a derivative of indomethacin, a well-known NSAID, and is used in the treatment of various inflammatory conditions.
Pharmacology[edit]
Glucametacin works by inhibiting the cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation and pain, and by reducing their production, glucametacin helps alleviate symptoms associated with inflammatory conditions.
Medical uses[edit]
Glucametacin is used in the management of conditions such as:
- Rheumatoid arthritis
- Osteoarthritis
- Ankylosing spondylitis
- Acute musculoskeletal disorders
Side effects[edit]
As with other NSAIDs, glucametacin can cause a range of side effects, including:
Mechanism of action[edit]

Glucametacin inhibits both COX-1 and COX-2 enzymes, though it has a higher affinity for COX-2. This selective inhibition reduces the production of pro-inflammatory prostaglandins while sparing those that protect the gastric mucosa and maintain renal blood flow.
Chemical properties[edit]
Glucametacin is chemically related to indomethacin, with modifications that enhance its pharmacokinetic profile. It is a lipophilic compound, which allows it to penetrate tissues effectively, contributing to its anti-inflammatory effects.
History[edit]
Glucametacin was developed as part of efforts to create NSAIDs with improved safety profiles compared to earlier drugs like indomethacin. Its development focused on reducing gastrointestinal side effects while maintaining efficacy.